Home > Insider Trading > Filing (0001209191-17-044232)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1435049	Aduro Biotech Inc.	ADRO	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1635590	W. Thomas Dubensky	C/O Aduro Biotech, Inc. 740 Heinz Avenue Berkeley CA 94710	Chief Scientific Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2017-07-03	11,800	$0.52	51,700	No	4	M	Direct
Common Stock	Disposition	2017-07-03	11,800	$11.02	39,900	No	4	S	Direct
Common Stock	Acquisiton	2017-07-05	33,688	$0.52	73,588	No	4	M	Direct
Common Stock	Disposition	2017-07-05	33,688	$11.46	39,900	No	4	S	Direct
Common Stock	Acquisiton	2017-07-06	4,512	$0.52	44,412	No	4	M	Direct
Common Stock	Disposition	2017-07-06	4,512	$11.23	39,900	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2017-07-03	11,800	$0.00	11,800	$0.52
Common Stock	Stock Option (Right to Buy)	Disposition	2017-07-05	33,688	$0.00	33,688	$0.52
Common Stock	Stock Option (Right to Buy)	Disposition	2017-07-06	4,512	$0.00	4,512	$0.52

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
51,771	2021-10-23	No	4	M	Direct
18,083	2021-10-23	No	4	M	Direct
13,571	2021-10-23	No	4	M	Direct

Footnotes

The sales reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2017.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.80 to $11.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.90 to $11.68, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.10 to $11.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The shares subject to the Option were fully vested as of September 1, 2015.